## KMX: CarMax Inc - XLY: Consumer Cyclical

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 4.7% in mid entry zone (3.0-6.0%), top quartile (88th pct) cross-sectional ranking. Short-term MRS_5 (4.1%) confirms momentum alignment. Strong momentum (+2.7% 5-day acceleration). Outperforming sector by 4.4%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($37.97)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX**
- Source: KXAN Austin | 20251208T081745 | Neutral | Relevance: 100%
-  The DJS Law Group has filed a class action lawsuit against CarMax, Inc. (NYSE: KMX) for alleged securities law violations, claiming the company made false and misleading statements regarding its growth prospects between June 20, 2025, and September 24, 2025. Shareholders who purchased KMX shares during this period and suffered losses are encouraged to contact the firm to discuss their rights and potential lead plaintiff appointments. The lawsuit alleges CarMax's growth was driven by customer speculation about tariffs, not sustainable fundamentals.

**2. Pomerantz LLP Issues Important Reminder to Shareholders in CarMax, Inc. of Class Action â€“ KMX**
- Source: Fox 59 | 20251208T230923 | Neutral | Relevance: 99%
-  Pomerantz LLP has announced a class action lawsuit against CarMax, Inc. (NYSE:KMX), reminding shareholders about the opportunity to become lead plaintiff. The lawsuit stems from CarMax's disappointing Q2 2026 financial results, where the company reported lower-than-expected EPS and sales, leading to a significant drop in its stock price. Investors who purchased CarMax securities during the Class Period have until January 2, 2026, to contact the firm.

**3. CARMAX, INC. (NYSE: KMX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds CarMax, Inc. Investors of Upcoming Deadline**
- Source: CBS 42 | 20251208T151409 | Neutral | Relevance: 99%
-  Bernstein Liebhard LLP has issued a shareholder alert for investors of CarMax, Inc. (NYSE: KMX) regarding an upcoming deadline in a securities fraud class action lawsuit. The lawsuit alleges that CarMax made misrepresentations concerning its growth prospects, impacting investors who purchased shares between June 20, 2025, and November 5, 2025. Investors have until January 2, 2026, to file papers to serve as lead plaintiff.

**4. Investors SueWallSt as CarMax, Inc. Faces Securities Fraud Allegations**
- Source: KRQE | 20251209T220844 | Neutral | Relevance: 99%
-  SueWallSt has announced a class action lawsuit against CarMax, Inc. for alleged securities fraud occurring between June 20, 2025, and November 5, 2025. Investors who suffered losses during this period are encouraged to contact Levi & Korsinsky for more information regarding their potential claim. The law firm Levi & Korsinsky, known for securing significant compensation for aggrieved shareholders, is leading this action.

**5. Evercore ISI Group Adjusts Price Target for CarMax (KMX) | KMX S**
- Source: GuruFocus | 20251209T160919 | Somewhat-Bullish | Relevance: 99%
-  Evercore ISI Group, led by analyst Michael Montani, has updated its rating for CarMax (KMX), maintaining an "In-Line" rating while increasing the price target from USD 35.00 to USD 37.00. This 5.71% adjustment suggests a slightly more optimistic outlook for CarMax's stock performance. The article also provides historical ratings from other firms and a company overview, noting mixed sentiments from analysts and an average "Hold" status across brokerage firms.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Evercore ISI Gr | $37 | $35 | +6% |
| 2025-11-18 | Wedbush | $40 | $40 | 0% |
| 2025-11-12 | Barclays | $28 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Evercore ISI Gr | main | In-Line |
| 2025-11-18 | Wedbush | reit | Neutral |
| 2025-11-12 | Barclays | init | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.59M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.5% (-3.8%)
- Blackrock Inc.: 7.8% (+5.9%)
- State Street Corpora: 3.8% (-2.2%)
- Janus Henderson Grou: 3.3% (+1.0%)
- Diamond Hill Capital: 3.3% (-30.6%)

### Key Risks

1. Elevated short interest (11.8%): bears positioning against stock.
2. Long-term trend broken: trading 30.2% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Momentum building: MRS_10 improving +2.7% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.57 indicates undervaluation relative to growth. Balance sheet: strong liquidity (2.5x). Analyst sentiment positive (1 raises, avg +6%). Insider buying signal ($0.6M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $6.2B |
| Beta | 1.29 |
| 52W Range | $30.26 - $91.25 |
| Short Interest | 11.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.57 |
| Forward P/E | 14.2 |
| Current P/E | 16.0 |
| YoY Growth | 12.6% |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from 2.0% to 4.7% (+2.7% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 88th percentile. MRS_5 at 4.1% confirms short-term momentum alignment. Outperforming sector by 4.4pp, stock-specific strength. Below SMA200 (0.70x), long-term trend not supportive. MACD histogram positive (0.81), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 4.70% (CS: 88) | Strong |
| RSI_14 | 61.5 | Neutral |
| MACD Histogram | 0.81 | Bullish |
| vs SMA20 | 1.120x | Above |
| vs SMA50 | 1.028x | Above |
| vs SMA200 | 0.698x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $41.21
- **Stop Loss:** $37.97 (7.9% risk)
- **Target:** $46.07 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 308
- **Position Value:** $12,692.68
- **Portfolio %:** 12.69%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with signs of improving risk appetite. Multiple major banks lowering prime rates suggest a dovish tilt in financial conditions ahead of the FOMC, while volatility remains subdued and breadth is moderate. Key drivers are easing lending rates, stable macro data, and improving sentiment, but selectivity is needed due to sector divergences.*

### Earnings

**Next:** 2025-12-18 (Est: $0.31)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.04 | $0.64 | -38.6% |
| 2025Q2 | $1.17 | $1.38 | +18.3% |
| 2025Q1 | $0.66 | $0.58 | -12.3% |
| 2024Q4 | $0.61 | $0.81 | +33.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*